Methotrexate offers a better alternative to corticosteroid treatment than anti-VEGF agents; however, the published data supporting the use of intravitreal methotrexate in the treatment of uveitis is still limited and is based on small case series (51). This evidence concerns the gene VEGFA and uveitis.